| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI115820 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC295927 |
| https://europepmc.org/articles/PMC295927?pdf=render | ||
| P932 | PMC publication ID | 295927 |
| P698 | PubMed publication ID | 1602014 |
| P2093 | author name string | J. A. Oliver | |
| D. W. Landry | |||
| P2860 | cites work | Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: a potential new approach to the management of ischemia-induced malignant ventricular arrhythmias | Q67286500 |
| The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells | Q69010313 | ||
| The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes | Q69034095 | ||
| Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle | Q69214240 | ||
| Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis | Q70054291 | ||
| Respiratory muscle fatigue during cardiogenic shock | Q71563159 | ||
| Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol | Q72222937 | ||
| EFFECT OF HEMORRHAGIC SHOCK ON THE REACTIVITY OF RESISTANCE AND CAPACITANCE VESSELS AND ON CAPILLARY FILTRATION TRANSFER IN CAT SKELETAL MUSCLE | Q76521314 | ||
| HEMODYNAMIC ASPECTS OF HEMORRHAGIC AND SEPTIC SHOCK | Q77147537 | ||
| Some circulatory responses to hemorrhage in the dog | Q80693197 | ||
| ATP-regulated K+ channels in cardiac muscle | Q28265565 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
| Adenosine 5'-triphosphate-sensitive potassium channels | Q28307662 | ||
| NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide | Q33575382 | ||
| BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle | Q33667326 | ||
| Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia | Q34173960 | ||
| Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine | Q35756026 | ||
| Special pharmacology of the new sulfonylurea glimepiride | Q36416462 | ||
| Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy | Q37943123 | ||
| Moving together: K+ channel openers and ATP-sensitive K+ channels | Q38753150 | ||
| The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation | Q39494636 | ||
| Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes | Q40342971 | ||
| The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients | Q41430318 | ||
| Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide | Q42478033 | ||
| Effect of H+ on ATP-regulated K+ channels in feline ventricular myocytes | Q42623306 | ||
| Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis | Q43540421 | ||
| Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation | Q43576077 | ||
| Pharmacokinetics of glyburide | Q44218568 | ||
| Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil. | Q44911448 | ||
| Activation of cardiac ATP-sensitive K+ current during hypoxia: correlation with tissue ATP levels | Q46073222 | ||
| Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels | Q46218245 | ||
| Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group | Q46886444 | ||
| Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. | Q50879461 | ||
| Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. | Q53790307 | ||
| Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular protons. | Q54099634 | ||
| Noradrenaline contracts arteries by activating voltage-dependent calcium channels. | Q54119697 | ||
| Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. | Q54399192 | ||
| Interleukin-1 receptor antagonist reduces mortality from endotoxin shock | Q59092106 | ||
| The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic and septic shock | Q59264989 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| endotoxemia | Q5832599 | ||
| hypotension | Q275419 | ||
| lactic acidosis | Q1500373 | ||
| P304 | page(s) | 2071-4 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog | |
| P478 | volume | 89 |
| Q39455583 | A Protective Role of Glibenclamide in Inflammation-Associated Injury. |
| Q44367911 | A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass |
| Q35042698 | Abnormal activation of K(+) channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence |
| Q41456255 | Actions of neurotransmitters and other messengers on Ca2+ channels and K+ channels in smooth muscle cells |
| Q73400449 | Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock |
| Q44070841 | Augmentation of NO-mediated vasodilation in metabolic acidosis |
| Q40690625 | Calcium desensitisation in late polymicrobial sepsis is associated with loss of vasopressor sensitivity in a murine model |
| Q37974559 | Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support |
| Q39473959 | Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM? |
| Q54568715 | Cardiovascular responses to glibenclamide during endotoxaemia in the pig. |
| Q50517883 | Cyclic GMP regulates cromakalim-induced relaxation in the rat aortic smooth muscle: role of cyclic GMP in K(ATP)-channels. |
| Q37938771 | Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. |
| Q55510405 | Definitions and pathophysiology of vasoplegic shock. |
| Q44106216 | Delayed rectifier potassium channels contribute to the depressed pulmonary artery contractility in pneumonia |
| Q46308815 | Deletion of proton-sensing receptor GPR4 associates with lower blood pressure and lower binding of angiotensin II receptor in SFO. |
| Q35045653 | Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity. |
| Q35044571 | Different mechanism of LPS-induced vasodilation in resistance and conductance arteries from SHR and normotensive rats |
| Q45023377 | Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock |
| Q35130561 | Early potassium channel blockade improves sepsis-induced organ damage and cardiovascular dysfunction. |
| Q44433845 | Effect of vasopressin on sublingual microcirculation in a patient with distributive shock |
| Q40653858 | Effects of ATP-sensitive potassium channel blockers on vascular hyporeactivity, mesenteric blood flow, and survival in lipopolysaccharide-induced septic shock model |
| Q73778367 | Focal exertional rhabdomyolysis associated with a hemangioma steal syndrome |
| Q34621483 | Functional roles of KATP channels in vascular smooth muscle |
| Q54453017 | Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels. |
| Q34793248 | Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. |
| Q44815180 | HMR1402, a potassium ATP channel blocker during hyperdynamic porcine endotoxemia: effects on hepato-splanchnic oxygen exchange and metabolism |
| Q71698249 | Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans |
| Q28343526 | Involvement of ATP-sensitive potassium channels in a model of a delayed vascular hyporeactivity induced by lipopolysaccharide in rats |
| Q46326847 | Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis |
| Q33863915 | Ion channels and the control of blood pressure. |
| Q42714463 | Is There NO Treatment For Severe Sepsis? |
| Q34044875 | K(ATP) channel action in vascular tone regulation: from genetics to diseases. |
| Q50527556 | K(ATP) channels do not mediate vasodilation by 3-morpholinosydnonimine in goat coronary artery. |
| Q33661652 | Lipopolysaccharides up-regulate Kir6.1/SUR2B channel expression and enhance vascular KATP channel activity via NF-kappaB-dependent signaling |
| Q37279918 | Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice |
| Q35048020 | Management of vasodilatory shock: defining the role of arginine vasopressin |
| Q47388010 | Mepivacaine attenuates vasodilation induced by ATP-sensitive potassium channels in rat aorta |
| Q37605024 | Molecular biology of K(ATP) channels and implications for health and disease |
| Q71750663 | Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels |
| Q36835542 | Nitric oxide in shock |
| Q28550687 | Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems |
| Q82866892 | Peripheral photoplethysmography variability analysis of sepsis patients |
| Q41906089 | Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide |
| Q37590213 | Revisiting steroid treatment for septic shock: molecular actions and clinical effects--a review |
| Q35753784 | Role of vasopressin in the management of septic shock |
| Q24805922 | Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology |
| Q51575264 | Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus. |
| Q39195631 | Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles |
| Q42537007 | Streptozotocin-induced diabetes enhances protective effects of enalapril on nitric oxide-deficient stroke in stroke-prone rats |
| Q46842196 | Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children |
| Q34680182 | The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia |
| Q24616935 | The impact of diabetes on the pathogenesis of sepsis |
| Q35048587 | The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro |
| Q37791460 | Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside |
| Q97543034 | Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies |
| Q45206636 | Vasopressin and terlipressin in sepsis and systemic inflammatory response syndrome. Effects on microcirculation, oxygen transport, metabolism and organ function |
| Q44647402 | Vasopressin in septic shock: Clinical equipoise mandates a time for restraint * |
| Q44506976 | Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects |
| Q83996147 | [Role of ketamine in sepsis and systemic inflammatory response syndrome] |
| Q81137611 | [Treatment of hemorrhagic shock. New therapy options] |
Search more.